An embolus in the right atrium caught in the Chiari network and resistant to thrombolysis
- PMID: 19894103
- DOI: 10.1007/s11239-009-0403-6
An embolus in the right atrium caught in the Chiari network and resistant to thrombolysis
Abstract
Case report is presented, which describes a patient with thromboemboli trapped in the Chiari network within the right heart and resistant to thrombolysis. The right atrial masses were completely removed under cardiopulmonary bypass. Histological evaluation confirmed a mixed thromboemboli, with thrombus structures showing signs of organization and surrounded by a fibrous capsule. A heterozygous methylenetetrahydrofolate reductase gene polymorphism was found, and the plasma level of the plasminogen activator inhibitor type-1 (PAI-1) was 50% higher than the normal upper limit. In this presented case, the Chiari network displayed a protective function, but the expansion and organization of the thromboembolus caught there made it resistant to lytic therapy. Another important factor which could have influenced the resistance to thrombolysis was the high level of PAI-1. PAI-1 is the primary physiologic inhibitor of plasminogen activation in blood. Elevated pre-treatment levels of PAI-1 may reduce the efficacy of thrombolytic therapy by preventing or retarding clot dissolution. The patient's DNA was tested for a common single-base-pair polymorphism (four or five guanine bases) in the promoter region of the gene (4G/5G), but the presence of this variant allele was not confirmed: the patient was homozygous for the 5G allele (5G/5G genotype).
Similar articles
-
An embolus in the right atrium caught in the Chiari network and resistant to thrombolysis.BMJ Case Rep. 2010 Sep 19;2010:bcr0920081019. doi: 10.1136/bcr.09.2008.1019. BMJ Case Rep. 2010. PMID: 22791494 Free PMC article.
-
PAI-1 4G/5G gene polymorphism is associated with angiographic patency in ST-elevation myocardial infarction patients treated with thrombolytic therapy.Coron Artery Dis. 2012 Sep;23(6):400-3. doi: 10.1097/MCA.0b013e3283576a77. Coron Artery Dis. 2012. PMID: 22850480
-
Influence of PAI-1 gene promoter-675 (4G/5G) polymorphism on fibrinolytic activity after cardiac surgery employing cardiopulmonary bypass.Medicina (Kaunas). 2012;48(10):515-20. Medicina (Kaunas). 2012. PMID: 23324247
-
Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation.Clin Exp Allergy. 2009 Aug;39(8):1136-44. doi: 10.1111/j.1365-2222.2009.03272.x. Epub 2009 May 5. Clin Exp Allergy. 2009. PMID: 19438580 Review.
-
Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.Vasa. 2020 Mar;49(2):141-146. doi: 10.1024/0301-1526/a000839. Epub 2020 Jan 10. Vasa. 2020. PMID: 31920171
Cited by
-
Chiari network: A case report and brief overview.J Saudi Heart Assoc. 2013 Jul;25(3):225-9. doi: 10.1016/j.jsha.2012.12.002. Epub 2013 Jan 8. J Saudi Heart Assoc. 2013. PMID: 24174864 Free PMC article.
-
Chiari network: a protective filter against pulmonary embolism in a case of polycythaemia.BMJ Case Rep. 2012 Apr 28;2012:bcr0520114289. doi: 10.1136/bcr.05.2011.4289. BMJ Case Rep. 2012. PMID: 22605001 Free PMC article.
-
A Nonfatal Massive Pulmonary Embolism in a Very Old Patient: The Protective Filter-Effect of the Chiari Network.J Cardiovasc Echogr. 2019 Jan-Mar;29(1):32-34. doi: 10.4103/jcecho.jcecho_65_18. J Cardiovasc Echogr. 2019. PMID: 31008038 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous